JP2019529459A5 - - Google Patents

Download PDF

Info

Publication number
JP2019529459A5
JP2019529459A5 JP2019515915A JP2019515915A JP2019529459A5 JP 2019529459 A5 JP2019529459 A5 JP 2019529459A5 JP 2019515915 A JP2019515915 A JP 2019515915A JP 2019515915 A JP2019515915 A JP 2019515915A JP 2019529459 A5 JP2019529459 A5 JP 2019529459A5
Authority
JP
Japan
Prior art keywords
mmol
mixture
stirred
trifluorophenyl
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2019515915A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019529459A (ja
Filing date
Publication date
Priority claimed from GBGB1616201.8A external-priority patent/GB201616201D0/en
Priority claimed from GBGB1713779.5A external-priority patent/GB201713779D0/en
Application filed filed Critical
Priority claimed from PCT/PT2017/050023 external-priority patent/WO2018056855A1/en
Publication of JP2019529459A publication Critical patent/JP2019529459A/ja
Publication of JP2019529459A5 publication Critical patent/JP2019529459A5/ja
Ceased legal-status Critical Current

Links

JP2019515915A 2016-09-23 2017-09-22 ドーパミン−b−ヒドロキシラーゼ阻害剤 Ceased JP2019529459A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1616201.8 2016-09-23
GBGB1616201.8A GB201616201D0 (en) 2016-09-23 2016-09-23 Blood-brain barrier-penetrant dopamine-B-hydroxylase inhibitors
GBGB1713779.5A GB201713779D0 (en) 2017-08-29 2017-08-29 Blood-brain barrier-penetrant dopamine B-hydroxylase inhibitors
GB1713779.5 2017-08-29
PCT/PT2017/050023 WO2018056855A1 (en) 2016-09-23 2017-09-22 Dopamine-b-hydroxylase inhibitors

Publications (2)

Publication Number Publication Date
JP2019529459A JP2019529459A (ja) 2019-10-17
JP2019529459A5 true JP2019529459A5 (enExample) 2021-10-14

Family

ID=60009687

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019515929A Pending JP2019529460A (ja) 2016-09-23 2017-09-22 血管脳関門透過剤ドーパミン−b−ヒドロキシラーゼ阻害剤
JP2019515915A Ceased JP2019529459A (ja) 2016-09-23 2017-09-22 ドーパミン−b−ヒドロキシラーゼ阻害剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2019515929A Pending JP2019529460A (ja) 2016-09-23 2017-09-22 血管脳関門透過剤ドーパミン−b−ヒドロキシラーゼ阻害剤

Country Status (20)

Country Link
US (3) US11034695B2 (enExample)
EP (2) EP3515917A1 (enExample)
JP (2) JP2019529460A (enExample)
KR (2) KR20190080864A (enExample)
CN (2) CN109715633B (enExample)
AU (2) AU2017330175B2 (enExample)
BR (2) BR112019004254A2 (enExample)
CA (2) CA3036650A1 (enExample)
CL (2) CL2019000662A1 (enExample)
CO (2) CO2019002523A2 (enExample)
IL (2) IL265138B (enExample)
JO (2) JOP20190049A1 (enExample)
MA (2) MA46273A (enExample)
MX (2) MX384293B (enExample)
PE (2) PE20190964A1 (enExample)
PH (2) PH12019500569A1 (enExample)
SG (2) SG11201901850XA (enExample)
TW (2) TW201817713A (enExample)
UA (2) UA123071C2 (enExample)
WO (2) WO2018056854A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190049A1 (ar) * 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز
JOP20190107A1 (ar) 2016-11-16 2019-05-09 Lundbeck La Jolla Research Center Inc مثبطات أحادي أسيل جليسرول ليباز (magl)
MA50041A (fr) 2017-08-29 2020-07-08 Lundbeck La Jolla Research Center Inc Composés spirocycliques et procédés de préparation et d'utilisation de ceux-ci
EP3720856A1 (en) 2017-12-04 2020-10-14 BIAL - PORTELA & Cª, S.A. Dopamine-& x392;-hydroxylase inhibitors
GB201908044D0 (en) 2019-06-05 2019-07-17 Bial Portela & Ca Sa Dopamine-B-Hydroxylase inhibitors
CN111675654A (zh) * 2020-07-22 2020-09-18 南开大学 一种以惰性环丙烷为原料合成四氢喹啉类化合物的方法
CN113354620B (zh) * 2021-07-05 2022-03-22 南京桦冠生物技术有限公司 一种特地唑胺中间体的高效制备方法及其中间体

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635982A (en) * 1969-04-08 1972-01-18 American Home Prod Amino-substituted-quinoxalinyloxazolidines and -oxazines
ES378317A1 (es) * 1969-04-11 1972-06-01 Robins Co Inc A H Un procedimiento para la preparacion de 3-fenilpirrolidinas1-sustituidas.
FR2449689A1 (fr) * 1979-02-20 1980-09-19 Logeais Labor Jacques Nouveaux derives condenses de pyrrolidine ou de piperidine, leur procede de preparation et leurs applications en therapeutique
US4728741A (en) * 1985-01-08 1988-03-01 Smithkline Beckman Corporation 1-substituted-2-mercapto benzimidazole compounds and intermediates
JPH04506967A (ja) * 1989-07-27 1992-12-03 ジー.ディー.サール アンド カンパニー 高血圧症治療用腎選択性生成物
JPH07173143A (ja) * 1993-12-17 1995-07-11 Wakamoto Pharmaceut Co Ltd 新規2−チオキソ−4−チアゾリジノン誘導体及び医薬
BR9507517A (pt) 1994-04-26 1997-09-16 Syntex Inc Derivados de benzocicloalquilazotetiona
US6482982B1 (en) 2001-03-09 2002-11-19 University Of Sciences Of Philadelphia Halogenated antituberculosis agents
US7125904B2 (en) * 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
WO2008085008A1 (en) * 2007-01-11 2008-07-17 Mogam Biotechnology Research Institute T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases
GB0708818D0 (en) * 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
AU2008279091A1 (en) 2007-07-23 2009-01-29 Biotie Therapies, Inc Treatment of post-traumatic stress disorder
EP2956441A4 (en) * 2013-02-18 2016-11-02 Scripps Research Inst MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL
JOP20190049A1 (ar) * 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز

Similar Documents

Publication Publication Date Title
JP2019529459A5 (enExample)
US8884016B2 (en) Apixaban preparation process
KR20180012788A (ko) 브리바라세탐의 제조 방법
JP6268093B2 (ja) 縮合複素環誘導体の製造方法およびその製造中間体
TW201605814A (zh) 用於合成經保護之n-烷基三唑甲醛的三唑中間體
WO2015131773A1 (zh) 作为食欲素受体拮抗剂的哌啶衍生物
JP5301431B2 (ja) キラルな環状β−アミノカルボキサミドの製造方法
TWI711604B (zh) 新穎4-苯并氮嚀衍生物的製造方法
WO2015018289A1 (zh) 一种合成阿哌沙班重要中间体的新方法
US10626102B2 (en) Process for the synthesis of efinaconazol
Fujisaki et al. Preparation and chemical properties of 5-dialkylaminomethylhydantoins and 2-thio-analogues
CN119264091B (zh) 一种1,5-双取代-3-氧杂双环[3.1.1]庚烷的合成方法
CN111410607B (zh) 六氢呋喃并呋喃醇衍生物的制备方法、其中间体及其制备方法
JP2012254991A (ja) テトラ置換−5−アザスピロ[2.4]へプタン誘導体の製法およびその光学活性中間体
JPWO2006123767A1 (ja) 不斉四置換炭素原子含有化合物の製法
EA026224B1 (ru) Способ получения 3,4-диметоксибицикло[4.2.0]окта-1,3,5-триен-7-карбонитрила и применение для получения ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
WO2008118935A1 (en) Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-ones
JP2010530397A (ja) アミド形成の改善方法
JP4596804B2 (ja) シラザプリルの製造方法
JP2008094744A (ja) ビスアミノールエーテル化合物を用いるピペリジン−4−オン誘導体の製造方法
JP6288588B2 (ja) N−スルフィニル−α−アミノアミドの製造方法
CN110944999A (zh) 中间体化合物和方法
CZ201741A3 (cs) Způsob přípravy vysoce opticky čistého (R)- 3-(4-(7H-pyrrolo[2,3-d] pyrimidin-4-yl)-lHpyrazol-l-yl)-3-cyclopentylpropan nitrilu
KR20070093656A (ko) 로사탄 및 그의 제조에 유용한 중간체인 벤질이미다졸유도체의 새로운 제조방법
JPWO2001017947A1 (ja) 2,3−ジヒドロアゼピン化合物の製造法